Legal Representation
Attorney
Cynthia Johnson Walden
USPTO Deadlines
Next Deadline
64 days remaining
NOA E-Mailed - SOU Required
Due Date
March 02, 2026
Extension Available
Until September 02, 2026
Application History
15 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Sep 2, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jul 8, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jul 8, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jul 2, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jun 2, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| May 8, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| May 8, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| May 8, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Mar 5, 2025 | GPRN | O | NOTIFICATION OF PRIORITY ACTION E-MAILED | Loading... |
| Mar 5, 2025 | GPRA | F | PRIORITY ACTION E-MAILED | Loading... |
| Mar 5, 2025 | CPRA | R | PRIORITY ACTION WRITTEN | Loading... |
| Feb 26, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 25, 2025 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Feb 25, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Aug 13, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations and substances containing rivoceranib for the treatment of cancer
Class 042
Development of therapeutics in the nature of pharmaceutical preparations for the treatment of cancer containing rivoceranib
Additional Information
Design Mark
The mark consists of the wording "TULVEGIO RIVOCERANIB" in stylized font. A stylized human hand design appears to the left of the letter "T" in the word "TULVEGIO".
Color Claim
Color is not claimed as a feature of the mark.
Translation
The wording "TULVEGIO" has no meaning in a foreign language.
Classification
International Classes
005
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"RIVOCERANIB"